To hear about similar clinical trials, please enter your email below
Trial Title:
Prospective Hyperthermia Database in Cancer Patients (HT Register)
NCT ID:
NCT05993910
Condition:
Hyperthermia
Cancer
Conditions: Official terms:
Hyperthermia
Fever
Conditions: Keywords:
Hyperthermia E02.565
HTRegister
Study type:
Observational [Patient Registry]
Overall status:
Recruiting
Study design:
Time perspective:
Prospective
Intervention:
Intervention type:
Other
Intervention name:
Hyperthermie Register
Description:
- die Höhe der Temperatur im Zielgebiet (42,5 bis 43 °C),
- die Dauer der Anwendung und
- die simultane Therapie mit Chemo- und/oder Strahlentherapie
Arm group label:
Hyperthermie Register
Summary:
This monocentric study registry records all cancer patients at the Charité which are
treated with hyperthermia to examine the therapeutic use of hyperthermia in cancer
patients in the general application and to obtain an accurate risk-benefit balance
After confinement in this database are the patients prospectively in order to
complications, disease status and survival status tracked.
Furthermore there is the possibility in the course of this study to an optional take part
in translational accompanying research with the aim of prognostic factors for response to
hyperthermia treatment.
Detailed description:
A total of 1000 patients with various diseases with the indication for hyperthermia in
addition to standard oncological therapy (radiation therapy, chemotherapy,
radiochemotherapy) will be included in this registry protocol.
Criteria for eligibility:
Study pop:
It is planned to include the first 1.000 patients in this prospective database. Because
of the characters in the database is a certain gender distribution not laid down .
Confinement are capable of all patients in the Charité , which has a hyperthermia
treatment , regardless of age or gender
Sampling method:
Non-Probability Sample
Criteria:
Inclusion Criteria:
- Contrazeption with female patients at the capable of bearing children age
- Written agreement is present (DvH, ICH-GCP)
- Patients, who participate at the same time in a interventional study, can
nevertheless in this register study participate if this none Exclusion criterion for
the interventional study represents.
- With children must the treatment with one of the GPOH agreed Pattern take place
Exclusion Criteria:
- Exclusion criteria for the hyperthermia (such as hip prosthesis in the therapeutic
area, metal implants/marker, patients with cardiac pacemakers)
- mental disease, what the proper study participation does not allow.
Gender:
All
Minimum age:
N/A
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Clinic for Radio - Oncology and Radiotherapy
Address:
City:
Berlin
Zip:
13353
Country:
Germany
Status:
Not yet recruiting
Contact:
Last name:
Pirus Ghadjar, Prof Dr.
Phone:
+4930450657055
Email:
pirus.ghadjar@charite.de
Facility:
Name:
Clinic for Radio - Oncology and Radiotherapy
Address:
City:
Berlin
Zip:
13353
Country:
Germany
Status:
Recruiting
Contact:
Last name:
Pirus Ghadjar, Prof. Dr.
Phone:
+4930450657055
Email:
pirus.ghadjar@charite.de
Start date:
November 1, 2014
Completion date:
October 31, 2028
Lead sponsor:
Agency:
Pirus Ghadjar
Agency class:
Other
Source:
Charite University, Berlin, Germany
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05993910
